Adjuvant Immunotherapy of Patients With High-Risk Melanoma Using Vaccinia Viral Lysates of Melanoma: Results of a Randomized Trial - Concepedia

Concepedia

Publication | Closed Access

Adjuvant Immunotherapy of Patients With High-Risk Melanoma Using Vaccinia Viral Lysates of Melanoma: Results of a Randomized Trial

149

Citations

28

References

2002

Year

Peter Hersey, Alan S. Coates, William H. McCarthy, John F. Thompson, Robert Sillar, Roderick McLeod, P. Grantley Gill, Brendon J. Coventry, Amanda McMullen, Haryana Dillon,

Journal of Clinical Oncology

Abstract

Immunotherapy with VMCL was not associated with a statistically significant improvement in OS or RFS, with CIs not ruling out important gains from such treatment.

References

	Year	Citations

Page 1